Should heroin be prescribed to heroin misusers? Yes

BMJ

Volumn 336, Issue 7635, 2008, Pages 70-

  Rehm, Jürgen ^a   Fischer, Benedikt ^b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF VICTORIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; METHADONE;

CLINICAL RESEARCH; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG DEPENDENCE; DRUG EFFICACY; DRUG SAFETY; ETHICS; HEALTH HAZARD; HEALTH SERVICE; HEROIN DEPENDENCE; INCIDENCE; MAINTENANCE THERAPY; PRESCRIPTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SHORT SURVEY; TREATMENT OUTCOME;

HEROIN; HEROIN DEPENDENCE; HUMANS; NARCOTICS; PRESCRIPTIONS, DRUG;

EID: 38349183069     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.39421.593692.94     Document Type: Article

References (16)

1. Fischer B, Oviedo-Joekes E, Blanken P, Haasen C, Rehm J, Schechter M, et al. Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics. J Urban Health 2007; 84: 552-62.
2. Koran L. Heroin maintenance for heroin addicts: Issues and evidence. N Engl J Med 1973; 288: 654-60.
3. Perneger T, Giner F, del Rio M, Mino A. Randomized trial of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ 1998; 317: 13-18.
4. Rehm J, Gschwend P, Steffen T, Gutzwiller F, Dobler-Mikola A, Uchtenhagen A. Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. Lancet 2001; 358: 1417-20.
5. Uchtenhagen A, Dobler-Mikola A, Steffen T, Gutzwiller F, Blattler R, Pfeifer S, eds. Prescription of narcotics for heroin addicts: main results of the Swiss national cohort study. Basel: Karger, 1999.
6. Van den Brink W, Hendriks V, Blanken P, Koeter M, van Zwieten B, van Ree J. Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ 2003; 327: 310-5.
7. Haasen C, Verthein U, Degkwitz P, Berger J, Krausz M, Naber D. Heroin assisted treatment for opioid dependence: a randomised, controlled trial. Br J Psychiatry 2007; 191: 55-62.
8. Frei A. Economic evaluation of the Swiss project on medically prescribed heroin substitution treatment. Psychiatrische Praxis 2001; 28: S41-S44.
9. Dijkgraaf M, van der Zanden B, de Borgie C, Blanken P, Van Ree J, Van den Brink W. Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. BMJ 2005; 330: 1297.
10. Metrebian N, Carnwath Z, Mott J, Carnwath T, Stimson G, Sell L. Patients receiving a prescription for diamorphine (heroin) in the United Kingdom. Drug Alcohol Rev 2006; 25: 115-21.
11. Amato L, Davoli M, Perucci C, Ferri M, Faggiano F, Mattick R. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat 2005; 28: 321-9.
12. Leshner A. Addiction is a brain disease, and it matters. Science 1997; 278: 45-47.
13. Stoermer R, Drewe J, Dursteler-Mac Farland K, Hock C, Mueller-Spahn F, Ladewig D, et al. Safety of injectable opioid maintenance treatment for heroin dependence. Biol Psychiatry 2003; 54: 854-61.
14. Rehm J, Frick U, Hartwig C, Gutzwiller F, Gschwend P, Uchtenhagen A. Mortality in heroin-assisted treatment in Switzerland 1994-2000. Drug Alcohol Depend 2005; 79: 137-43.
15. Bammer G, van den Brink W, Gschwend P, Hendriks V, Rehm J. What can the Swiss and Dutch trials tell us about the potential risks associated with heroin prescribing? Drug Alcohol Rev 2003; 22: 363-71.
16. Nordt C, Stohler R. Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis. Lancet 2006; 367: 1830-4.